LEVONORGESTREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levonorgestrel, and what generic alternatives are available?
Levonorgestrel is a drug marketed by Wyeth Pharms Inc, Alvogen, Fdn Consumer, Glenmark Pharms Ltd, L Perrigo Co, Laboratoire Hra, Lotus Pharm Co Ltd, Lupin Ltd, Naari Pte Ltd, Novel Labs Inc, Perrigo R And D, Watson Labs, Xiromed, Amneal Pharms, Barr, Dr Reddys Labs Sa, and Hetero Labs. and is included in forty-six NDAs.
The generic ingredient in LEVONORGESTREL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVONORGESTREL?
- What are the global sales for LEVONORGESTREL?
- What is Average Wholesale Price for LEVONORGESTREL?
Summary for LEVONORGESTREL
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 46 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 252 |
| Patent Applications: | 3,672 |
| Drug Prices: | Drug price information for LEVONORGESTREL |
| What excipients (inactive ingredients) are in LEVONORGESTREL? | LEVONORGESTREL excipients list |
| DailyMed Link: | LEVONORGESTREL at DailyMed |
See drug prices for LEVONORGESTREL
Recent Clinical Trials for LEVONORGESTREL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alexion Pharmaceuticals, Inc. | Phase 1 |
| Lori Gawron | Phase 4 |
| Planned Parenthood Association of Utah | Phase 4 |
Pharmacology for LEVONORGESTREL
| Drug Class | Progestin Progestin-containing Intrauterine Device Progestin-containing Intrauterine System |
| Physiological Effect | Inhibit Ovum Fertilization |
Medical Subject Heading (MeSH) Categories for LEVONORGESTREL
Anatomical Therapeutic Chemical (ATC) Classes for LEVONORGESTREL
US Patents and Regulatory Information for LEVONORGESTREL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 078834-001 | May 31, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lupin Ltd | LEVONORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 091425-001 | Jan 18, 2013 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Xiromed | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 205131-001 | Dec 14, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Barr | LEVONORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 075862-002 | Apr 29, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin Ltd | LEVONORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 200248-001 | Nov 19, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
